No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population

Diabetologia

Volumn 54, Issue 8, 2011, Pages 2025-2032

  Pfister, R ^a,b   Sharp, S J ^a   Luben, R ^c   Khaw, K T ^c   Wareham, N J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HbA1c; Low glycaemia; Mortality

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CIGARETTE SMOKING; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HEART INFARCTION; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; WAIST HIP RATIO;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MORTALITY; RISK FACTORS;

EID: 79960923452     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2162-0     Document Type: Article

References (29)

1. Association AD (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62-S69
2. Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800-811
3. Carson AP, Fox CS, McGuire DK et al (2010) Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes 3:661-667
4. Currie CJ, Peters JR, Tynan A et al (2010) Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375:481-489
5. Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559 (Pubitemid 351831356)
6. Brewer N, Wright CS, Travier N et al (2008) A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care 31:1144-1149
7. Levitan EB, Liu S, Stampfer MJ et al (2008) HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia 51:267-275
8. de Vegt F, Dekker JM, Ruhe HG et al (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926-931 (Pubitemid 29369599)
9. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE (2009) Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) Study. Diabetologia 52:415-424
10. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413-420
11. Khaw KT, Wareham N, Luben R et al (2001) Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322:15-18 (Pubitemid 32066250)
12. Day N, Oakes S, Luben R et al (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80(Suppl 1):95-103 (Pubitemid 29389613)
13. Khaw KT, Dowsett M, Folkerd E et al (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116:2694-2701 (Pubitemid 350291241)
14. Firth D (2003) Overcoming the reference category problem in the presentation of statistical models. Sociol Methodol 33:1-18
15. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233-240 (Pubitemid 29056916)
16. Ford ES, Zhao G, Li C (2010) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 55:1310-1317
17. Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215-2222
18. Van't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM (2010) Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn Study. Diabetes Care 33:61-66
19. Gerstein HC (2010) More insights on the dysglycaemia-cardiovascular connection. Lancet 375:2195-2196
20. Lin J, Ridker PM, Pradhan A et al (2005) Hemoglobin A1c concentrations and risk of colorectal cancer in women. Cancer Epidemiol Biomark Prev 14:3010-3012 (Pubitemid 43068841)
21. Lin J, Ridker PM, Rifai N et al (2006) A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer Res 66:2869-2875
22. Rinaldi S, Rohrmann S, Jenab M et al (2008) Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 17:3108-3115
23. Travier N, Jeffreys M, Brewer N et al (2007) Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol 18:1414-1419 (Pubitemid 47305017)
24. Riddle MC, Ambrosius WT, Brillon DJ et al (2010) Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 33:983-990
25. Bonds DE, Miller ME, Bergenstal RM et al (2010) The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD Study. BMJ 340:b4909
26. Calles-Escandon J, Lovato LC, Simons-Morton DG et al (2010) Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 33:721-727
27. Ziemer DC, Kolm P, Weintraub WS et al (2010) Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 152:770-777
28. Franceschi S, Lise M, Trepo C et al (2011) Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomark Prev 20:208-214
29. Rohlfing C, Wiedmeyer HM, Little R et al (2002) Biological variation of glycohemoglobin. Clin Chem 48:1116-1118 (Pubitemid 34680915)